Sage Journals: Discover world-class research

Abstract

Keywords

anti-inflammatory agents nonsteroidal pityriasis rubra pilaris psoriasis treatment systemic therapy skin diseases papulosquamous

Get full access to this article

View all access options for this article.

References

Albert

Mackool

. Pityriasis rubra pilaris. Int J Dermatol. 1999;38:1-11.

Ross

Chung

H-J

Andrews

Keller

Uitto

. Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris. JAMA Dermatol. 2016;152:1-6.

Kumar

Goldminz

Kim

Gottlieb

. Phosphodiesterase 4-targeted treatments for autoimmune diseases. BMC Med. 2013;11:96.

Wittmann

Helliwell

. Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther (Heidelb). 2013;3:1-15.

Krase

Cavanaugh

Curiel-Lewandrowski

. Treatment of refractory pityriasis rubra pilaris with novel phosphodiesterase 4 (PDE4) inhibitor apremilast. JAMA Dermatol. 2016;152:348-350.

Successful Treatment of Refractory Type 1 Pityriasis Rubra Pilaris With Apremilast

Abstract

Keywords

Get full access to this article

References